Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Profectus BioSciences begins immunization with HIV vaccine in phase I trial

Jan. 9, 2012

FDA accepts NDA for Quad HIV regimen

Dec. 29, 2011

Researchers begin first clinical study of new HIV vaccine

Dec. 28, 2011

Japan Tobacco and Gilead Sciences enter licensing agreement

Dec. 28, 2011

FDA grants new approval for Isentress

Dec. 28, 2011

EMA validates MAA for single-tablet HIV-1 therapy

Dec. 23, 2011

Gilead Sciences submits sNDA for Truvada

Dec. 20, 2011

GeoVax Labs vaccinates first patient in phase I/II AIDS trial

Dec. 16, 2011

New topline data released from elvitegravir trial

Dec. 12, 2011

Pivotal trial of cobicistat meets primary endpoint

Dec. 7, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...